| Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines C Kearon, EA Akl, AJ Comerota, P Prandoni, H Bounameaux, ... Chest 141 (2), e419S-e496S, 2012 | 9973* | 2012 |
| 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The Task Force for the … SV Konstantinides, G Meyer, C Becattini, H Bueno, GJ Geersing, ... European heart journal 41 (4), 543-603, 2020 | 9778* | 2020 |
| COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... Journal of the American college of cardiology 75 (23), 2950-2973, 2020 | 3523 | 2020 |
| Genomewide Association Study of Severe Covid-19 with Respiratory Failure N Engl J Med, 2020 | 2033* | 2020 |
| Fibrinolysis for patients with intermediate-risk pulmonary embolism G Meyer, E Vicaut, T Danays, G Agnelli, C Becattini, J Beyer-Westendorf, ... New England Journal of Medicine 370 (15), 1402-1411, 2014 | 1918 | 2014 |
| Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism D Jiménez, D Aujesky, L Moores, V Gómez, JL Lobo, F Uresandi, R Otero, ... Archives of internal medicine 170 (15), 1383-1389, 2010 | 1526 | 2010 |
| Clinical predictors for fatal pulmonary embolism in 15 520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa … S Laporte, P Mismetti, H Décousus, F Uresandi, R Otero, JL Lobo, ... Circulation 117 (13), 1711-1716, 2008 | 971 | 2008 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 844 | 2021 |
| Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report LK Moores, T Tritschler, S Brosnahan, M Carrier, JF Collen, K Doerschug, ... Chest 158 (3), 1143-1163, 2020 | 734 | 2020 |
| Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With … I Investigators JAMA 325 (16), 1620-1630, 2021 | 721* | 2021 |
| Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry N Ruíz-Giménez, C Suárez, R González, JA Nieto, JA Todolí, ... Thrombosis and haemostasis 100 (07), 26-31, 2008 | 585 | 2008 |
| Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis D Jiménez, A García-Sanchez, P Rali, A Muriel, B Bikdeli, P Ruiz-Artacho, ... Chest 159 (3), 1182-1196, 2021 | 533 | 2021 |
| Prospective validation of the pulmonary embolism severity index J Donzé, G Le Gal, MJ Fine, PM Roy, O Sanchez, F Verschuren, J Cornuz, ... Thrombosis and haemostasis 100 (05), 943-948, 2008 | 453 | 2008 |
| Trends in the management and outcomes of acute pulmonary embolism: analysis from the RIETE registry D Jiménez, J de Miguel-Díez, R Guijarro, J Trujillo-Santos, R Otero, ... Journal of the American College of Cardiology 67 (2), 162-170, 2016 | 435 | 2016 |
| Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and thrombotic or … B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... J Am Coll Cardiol 75 (23), 2950-2973, 2020 | 420 | 2020 |
| Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry FJ Muñoz, P Mismetti, R Poggio, R Valle, M Barrón, M Guil, M Monreal, ... Chest 133 (1), 143-148, 2008 | 384 | 2008 |
| Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism … M Lankeit, D Jiménez, M Kostrubiec, C Dellas, G Hasenfuss, P Pruszczyk, ... Circulation 124 (24), 2716-2724, 2011 | 369 | 2011 |
| Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism SV Konstantinides, E Vicaut, T Danays, C Becattini, L Bertoletti, ... Journal of the American College of Cardiology 69 (12), 1536-1544, 2017 | 367 | 2017 |
| Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research B Bikdeli, MV Madhavan, A Gupta, D Jimenez, JR Burton, ... Thrombosis and haemostasis 120 (07), 1004-1024, 2020 | 303 | 2020 |
| 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 D Farge, C Frere, JM Connors, AA Khorana, A Kakkar, C Ay, A Muñoz, ... The Lancet Oncology 23 (7), e334-e347, 2022 | 290 | 2022 |
Behnood Bikdeli, MD, MSBrigham and Women's Hospital, Harvard Medical School, Yale/ YNHH Center for Outcomes Research andAdresse e-mail validée de yale.edu